SEC Form 4 · accession 0001127602-15-027800
UNITED THERAPEUTICS Corp · UTHR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Tommy G Thompson
Director
Period of report
Sep 29, 2015
Accepted (ET)
Sep 29, 2015 · 4:21 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001082554
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 29, 2015 | M | 5,000 | $51.77 | A | 5,000 | D | |
| Common StockF1 | Sep 29, 2015 | S | 5,000 | $139.1869 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options | $51.77 | Sep 29, 2015 | M | 5,000 | D | Jun 28, 2011 | Jun 28, 2020 | Common Stock | 5,000 | 8,500 | D |
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $138.80 to $139.51. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.